Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Shadman M, Salkar M, Srivastava B, Karve S, Emond B, Gogna P, Manceur AM, Lafeuille MH, Rava A, Sun H, Howarth A, Tomicki S, Agatep B, Jones B, Franceschini E, Saifan C, Bacchus S, Roeker L, Stephens DM.
Shadman M, et al. Among authors: salkar m.
Leuk Lymphoma. 2024 Oct 1:1-10. doi: 10.1080/10428194.2024.2402814. Online ahead of print.
Leuk Lymphoma. 2024.
PMID: 39352001